TOP TIERMARKET NEWSWIRE
News & sentiment

AQUESTIVE THERAPEUTI (AQST) — News & AI sentiment

AQUESTIVE THERAPEUTI (AQST) news roundup. 12 stories in the past week, 25 over 30 days. Average 30-day sentiment is 56.6/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 4 sales totalling $379K — net selling of $379K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
12
avg sentiment 53.9/100
30d stories
25
avg sentiment 56.6/100
Insider net (90d)
$379K
0 buys · 4 sells
Congress (90d)
0
0 buys · 0 sells

AQST news in the last 24 hours, 7 days, 30 days and 90 days

How much AQST coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowAQST storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days1253.9/100AQST headlines →
Last 30 days2556.6/100AQST headlines →
Last 90 days5554.7/100AQST headlines →

Latest stories on AQST

2d ago
3d ago
4d ago
4d ago
4d ago
Aquestive (AQST) Q3 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
5d ago
5d ago
5d ago
5d ago
5d ago
5d ago
7d ago
Oct 27
Oct 19
Oct 16
H.C. Wainwright reiterates Aquestive stock rating on FDA review
Investing.com Analyst Ratings52 · neutralanalyst
Oct 16
Aquestive NDA for Anaphylm Accepted by FDA
TipRanks63 · neutralproduct/pr
Oct 15
Oct 15
Oct 15
Oct 15
Oct 14
Oct 14
Oct 14
Oct 14
Oct 14
Open AQST in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →